Morgan Stanley’s Biofrontera AG American Depositary Shares BFRA Stock Holding History

Morgan Stanley’s Portfolio BFRA Stock Details BFRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-14,900	Closed	-$44K	–	8347
2021 Q4	$44K	Buy	14,900 +600	+4%	+$2.7K	﹤0.01%	6881
2021 Q3	$76K	Sell	14,300 -5,662	-28%	-$33.4K	﹤0.01%	6519
2021 Q2	$128K	Sell	19,962 -58,059	-74%	-$354K	﹤0.01%	6238
2021 Q1	$417K	Buy	78,021 +73,349	+1,570%	+$521K	﹤0.01%	5252
2020 Q4	$34K	Buy	+4,672	New	+$33.5K	﹤0.01%	6278

Morgan Stanley's BFRA Position: Q1 2022 in Review

Morgan Stanley sold out of Biofrontera AG American Depositary Shares (BFRA) in Q1 2022, closing a stake of 14,900 shares — an estimated $44K sold.

Morgan Stanley first reported a position in BFRA in Q4 2020 and held it in 5 quarters. The position peaked at $417K in Q1 2021. 0 funds tracked by Wall St. Rank hold BFRA as of Q1 2022.

Morgan Stanley reported no remaining Biofrontera AG American Depositary Shares position as of Q1 2022 after selling out during the quarter.
Morgan Stanley sold 14,900 Biofrontera AG American Depositary Shares shares in Q1 2022, an estimated $44K.
Morgan Stanley first reported a position in Biofrontera AG American Depositary Shares in Q4 2020 and held it in 5 quarters.
Morgan Stanley's Biofrontera AG American Depositary Shares position peaked at $417K in Q1 2021.
0 funds tracked by Wall St. Rank held Biofrontera AG American Depositary Shares as of Q1 2022.

Based on Morgan Stanley's 13F filing for Q1 2022, filed 13 May 2022.